VivoSim Labs, INC. (VIVS) — Institutional Holders, Q2 2026
26 institutional investment managers reported a VIVS position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $109.7K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
VIVS in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- RENAISSANCE TECHNOLOGIESNew · +18,500 sh+$19.8K
- HRT FINANCIALNew · +18,319 sh+$19.6K
- Tower Research Capital (TRC)Added · +2,941 sh+$3.1K
- IFG AdvisoryNew · +14 sh+$15.00
- Caitong International Asset Management , LtdAdded · +14 sh+$15.00
Biggest sellers
- GOLDMAN SACHS GROUPSold out · -16,072 sh-$17.2K
- GEODE CAPITAL MANAGEMENTTrimmed · -10,874 sh-$11.6K
- CITIGROUPSold out · -6,504 sh-$7.0K
- UBS Group AGTrimmed · -934 sh-$999.00
- Allworth FinancialSold out · -208 sh-$223.00
VIVS 13F holders ranked 1–26 of 26
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT#1 · 25,976 sh | 25,976 | $27.8K | 0.00% | -29.5% |
| 2 | RENAISSANCE TECHNOLOGIES#2 · 18,500 sh | 18,500 | $19.8K | 0.00% | New |
| 3 | HRT FINANCIAL#3 · 18,319 sh | 18,319 | $19.0K | 0.00% | New |
| 4 | VANGUARD CAPITAL MANAGEMENT#4 · 15,371 sh | 15,371 | $16.4K | 0.00% | 0.0% |
| 5 | BlackRock#5 · 11,817 sh | 11,817 | $12.6K | 0.00% | 0.0% |
| 6 | VANGUARD FIDUCIARY#6 · 7,003 sh | 7,003 | $7.5K | 0.00% | 0.0% |
| 7 | Tower Research Capital (TRC)#7 · 5,249 sh | 5,249 | $5.6K | <0.01% | +127.4% |
| 8 | SBI Securities , Ltd.#8 · 221 sh | 221 | $236.00 | — | 0.0% |
| 9 | Larson Financial Group#9 · 166 sh | 166 | $178.00 | 0.00% | 0.0% |
| 10 | ALBION FINANCIAL GROUP#10 · 159 sh | 159 | $171.00 | — | 0.0% |
| 11 | WELLS FARGO & COMPANY#11 · 111 sh | 111 | $119.00 | 0.00% | 0.0% |
| 12 | OSAIC#12 · 84 sh | 84 | $88.00 | 0.00% | -11.6% |
| 13 | MORGAN STANLEY#13 · 49 sh | 49 | $52.00 | 0.00% | -2.0% |
| 14 | UBS Group AG#14 · 18 sh | 18 | $20.00 | 0.00% | -98.1% |
| 15 | Caitong International Asset Management , Ltd#15 · 17 sh | 17 | $18.00 | 0.00% | +466.7% |
| 16 | IFG Advisory#16 · 14 sh | 14 | $15.00 | 0.00% | New |
| 17 | Integrated Wealth Concepts#17 · 8 sh | 8 | $9.00 | 0.00% | New |
| 18 | Rockefeller Capital Management L.P.#18 · 2 sh | 2 | $2.00 | 0.00% | 0.0% |
| 19 | Golden State Wealth Management#19 · 2 sh | 2 | $2.00 | 0.00% | 0.0% |
| 20 | Activest Wealth Management#20 · 2 sh | 2 | $2.00 | — | 0.0% |
| 21 | Federation des caisses Desjardins du Quebec#21 · 2 sh | 2 | $2.00 | 0.00% | 0.0% |
| 22 | First Command Advisory Services#22 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
| 23 | Hilton Head Capital Partners#23 · 1 sh | 1 | $1.00 | — | 0.0% |
| 24 | HARBOUR INVESTMENTS#24 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
| 25 | ROYAL BANK OF CANADA#25 · 1 sh | 1 | $0.00 | 0.00% | -50.0% |
| 26 | FNY Investment Advisers#26 · 200 sh | 200 | $0.00 | — | New |
Funds that sold out of VIVS in Q2 2026 (3)
Held VIVS at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| GOLDMAN SACHS GROUP16,072 sh | 16,072 | $23.0K |
| CITIGROUP6,504 sh | 6,504 | $9.3K |
| Allworth Financial208 sh | 208 | $298.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.